These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 31199462)

  • 1. Stratifying drug treatment of cognitive impairments after traumatic brain injury using neuroimaging.
    Jenkins PO; De Simoni S; Bourke NJ; Fleminger J; Scott G; Towey DJ; Svensson W; Khan S; Patel MC; Greenwood R; Friedland D; Hampshire A; Cole JH; Sharp DJ
    Brain; 2019 Aug; 142(8):2367-2379. PubMed ID: 31199462
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dopaminergic abnormalities following traumatic brain injury.
    Jenkins PO; De Simoni S; Bourke NJ; Fleminger J; Scott G; Towey DJ; Svensson W; Khan S; Patel M; Greenwood R; Cole JH; Sharp DJ
    Brain; 2018 Mar; 141(3):797-810. PubMed ID: 29360949
    [TBL] [Abstract][Full Text] [Related]  

  • 3.
    Womack KB; Dubiel R; Callender L; Dunklin C; Dahdah M; Harris TS; Devous MD; Juengst SB; Bell K; Diaz-Arrastia R; Ding K
    J Neurotrauma; 2020 Oct; 37(19):2113-2119. PubMed ID: 32216525
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Methylphenidate-mediated motor control network enhancement in patients with traumatic brain injury.
    Dorer CL; Manktelow AE; Allanson J; Sahakian BJ; Pickard JD; Bateman A; Menon DK; Stamatakis EA
    Brain Inj; 2018; 32(8):1040-1049. PubMed ID: 29738277
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of Methylphenidate on Long-Term Neuropsychological and Everyday Executive Functioning After Traumatic Brain Injury in Children with Secondary Attention Problems.
    LeBlond E; Smith-Paine J; Riemersma JJ; Horn PS; Wade SL; Kurowski BG
    J Int Neuropsychol Soc; 2019 Aug; 25(7):740-749. PubMed ID: 31178001
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of methylphenidate in the rehabilitation of attention following traumatic brain injury: a randomised, crossover, double blind, placebo controlled inpatient trial.
    Willmott C; Ponsford J
    J Neurol Neurosurg Psychiatry; 2009 May; 80(5):552-7. PubMed ID: 19060022
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The efficacy and safety of extended-release methylphenidate following traumatic brain injury: a randomised controlled pilot study.
    Dymowski AR; Ponsford JL; Owens JA; Olver JH; Ponsford M; Willmott C
    Clin Rehabil; 2017 Jun; 31(6):733-741. PubMed ID: 27353245
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of methylphenidate on attention deficits after traumatic brain injury: a multidimensional, randomized, controlled trial.
    Whyte J; Hart T; Vaccaro M; Grieb-Neff P; Risser A; Polansky M; Coslett HB
    Am J Phys Med Rehabil; 2004 Jun; 83(6):401-20. PubMed ID: 15166683
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Methylphenidate on Cognitive Improvement in Patients with Traumatic Brain Injury: A Meta-Analysis.
    Huang CH; Huang CC; Sun CK; Lin GH; Hou WH
    Curr Neuropharmacol; 2016; 14(3):272-81. PubMed ID: 26951094
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Methylphenidate and galantamine in patients with vascular cognitive impairment-the proof-of-principle study STREAM-VCI.
    Leijenaar JF; Groeneveld GJ; Klaassen ES; Leeuwis AE; Scheltens P; Weinstein HC; van Gerven JMA; Barkhof F; van der Flier WM; Prins ND
    Alzheimers Res Ther; 2020 Jan; 12(1):10. PubMed ID: 31910895
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term treatment with methylphenidate for fatigue after traumatic brain injury.
    Johansson B; Wentzel AP; Andréll P; Rönnbäck L; Mannheimer C
    Acta Neurol Scand; 2017 Jan; 135(1):100-107. PubMed ID: 26991608
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Methylphenidate and Memory and Attention Adaptation Training for Persistent Cognitive Symptoms after Traumatic Brain Injury: A Randomized, Placebo-Controlled Trial.
    McDonald BC; Flashman LA; Arciniegas DB; Ferguson RJ; Xing L; Harezlak J; Sprehn GC; Hammond FM; Maerlender AC; Kruck CL; Gillock KL; Frey K; Wall RN; Saykin AJ; McAllister TW
    Neuropsychopharmacology; 2017 Aug; 42(9):1766-1775. PubMed ID: 27874023
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Follow-up after 5.5 years of treatment with methylphenidate for mental fatigue and cognitive function after a mild traumatic brain injury.
    Johansson B; Andréll P; Rönnbäck L; Mannheimer C
    Brain Inj; 2020; 34(2):229-235. PubMed ID: 31657646
    [No Abstract]   [Full Text] [Related]  

  • 14. Long-term stimulant treatment affects brain dopamine transporter level in patients with attention deficit hyperactive disorder.
    Wang GJ; Volkow ND; Wigal T; Kollins SH; Newcorn JH; Telang F; Logan J; Jayne M; Wong CT; Han H; Fowler JS; Zhu W; Swanson JM
    PLoS One; 2013; 8(5):e63023. PubMed ID: 23696790
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anything goes? Regulation of the neural processes underlying response inhibition in TBI patients.
    Moreno-López L; Manktelow AE; Sahakian BJ; Menon DK; Stamatakis EA
    Eur Neuropsychopharmacol; 2017 Feb; 27(2):159-169. PubMed ID: 28012706
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of methylphenidate on cognition and behaviour in children with neurofibromatosis type 1: a study protocol for a randomised placebo-controlled crossover trial.
    Pride NA; Barton B; Hutchins P; Coghill DR; Korgaonkar MS; Hearps SJC; Rouel M; Malarbi S; North KN; Payne JM
    BMJ Open; 2018 Aug; 8(8):e021800. PubMed ID: 30166301
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of methylphenidate for the treatment of mental sequelae after traumatic brain injury.
    Zhang WT; Wang YF
    Medicine (Baltimore); 2017 Jun; 96(25):e6960. PubMed ID: 28640076
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Subacute methylphenidate treatment for moderate to moderately severe traumatic brain injury: a preliminary double-blind placebo-controlled study.
    Plenger PM; Dixon CE; Castillo RM; Frankowski RF; Yablon SA; Levin HS
    Arch Phys Med Rehabil; 1996 Jun; 77(6):536-40. PubMed ID: 8831468
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Methylphenidate for the treatment of apathy in Alzheimer disease: prediction of response using dextroamphetamine challenge.
    Herrmann N; Rothenburg LS; Black SE; Ryan M; Liu BA; Busto UE; Lanctôt KL
    J Clin Psychopharmacol; 2008 Jun; 28(3):296-301. PubMed ID: 18480686
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The homozygosity for 10-repeat allele at dopamine transporter gene and dopamine transporter density in Korean children with attention deficit hyperactivity disorder: relating to treatment response to methylphenidate.
    Cheon KA; Ryu YH; Kim JW; Cho DY
    Eur Neuropsychopharmacol; 2005 Jan; 15(1):95-101. PubMed ID: 15572278
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.